Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Current Leases (2022 - 2025)

Rani Therapeutics Holdings has reported Current Leases over the past 4 years, most recently at $1.6 million for Q4 2025.

  • Quarterly results put Current Leases at $1.6 million for Q4 2025, up 8.7% from a year ago — trailing twelve months through Dec 2025 was $1.6 million (up 8.7% YoY), and the annual figure for FY2025 was $1.6 million, up 8.7%.
  • Current Leases for Q4 2025 was $1.6 million at Rani Therapeutics Holdings, up from $1.0 million in the prior quarter.
  • Over the last five years, Current Leases for RANI hit a ceiling of $1.6 million in Q4 2025 and a floor of $650000.0 in Q1 2022.
  • Median Current Leases over the past 4 years was $1.0 million (2022), compared with a mean of $1.1 million.
  • Biggest five-year swings in Current Leases: fell 28.63% in 2023 and later soared 103.2% in 2024.
  • Rani Therapeutics Holdings' Current Leases stood at $1.0 million in 2022, then fell by 28.63% to $718000.0 in 2023, then soared by 103.2% to $1.5 million in 2024, then rose by 8.7% to $1.6 million in 2025.
  • The last three reported values for Current Leases were $1.6 million (Q4 2025), $1.0 million (Q3 2025), and $1.2 million (Q2 2025) per Business Quant data.